Comparison the Effect of Aspirin and Enoxaparin on the prevention of deep venous thrombosis in patients with ankle sprain with immobilization of lower extremities in the form of short plaster

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120726010405N5

Enrollment

195

Registered

2018-03-10

Start date

2017-05-22

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sprain of ankle. Sprain of ankle

Interventions

Intervention 1: ?First Intervention group: Aspirin Tablets with dose of 325 mg/day for 3 weeks. Intervention 2: Second Intervention group:Enoxaparin, brand name of Clexane, with a dose of 40 mg daily

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Age greater than or equal to 15 years Ankle Sprain on the lateral side: Grade 2 and 3

Exclusion criteria

Exclusion criteria: Ankle instability Medial Ankle injury Syndesmosis damage Wound on the site of injury The presence of other fractures People who have an anticoagulant use history

Design outcomes

Primary

Measure	Time frame
D-Dimer value in the D-Dimer test. Timepoint: Measurement of D-Dimer Test at before intervention and 21 days after administration of Aspirin and ?Enoxaparin. Method of measurement: D-Dimer Test kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr seyed Mehran Razavipour

Sari University of Medical Sciences

m.razavipour@mazums.ac.ir+98 11 3337 7169

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026